vimarsana.com

Verastem Oncology (VSTM) Announces Initiation of a Confirmatory Phase 3 Trial of Avutometinib and Defactinib in Recurrent Low-Grade Serous Ovarian Cancer

Verastem Oncology (VSTM) Announces Initiation of a Confirmatory Phase 3 Trial of Avutometinib and Defactinib in Recurrent Low-Grade Serous Ovarian Cancer

streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

London ,City Of ,United Kingdom ,Australia ,Canada ,Dan Paterson ,Rachel Grisham ,Susana Banerjee ,Drug Administration ,Institute Of Cancer Research ,Foundation Inc ,Company Phase ,Research Lead For The Gynaecology Unit ,European Network Of Gynaecological Oncological Trial ,Team Leader In Women Cancers ,Verastem Oncology ,Chief Executive Officer ,Breakthrough Therapy Designation ,Accelerated Approval ,Accelerated Approval New Drug Application ,Section Head ,Ovarian Cancer ,Gynecologic Medical Oncology ,Memorial Sloan Kettering Cancer Center ,Professor Susana Banerjee ,Consultant Medical Oncologist ,Research Lead ,Gynaecology Unit ,Royal Marsden ,Team Leader ,Cancer Research ,European Network ,Gynaecological Oncological Trial ,Blinded Independent Central ,

vimarsana.com © 2020. All Rights Reserved.